This is a demo store. No orders will be fulfilled.

Fremanezumab (anti-CALCA), 降钙素基因相关肽拮抗剂的拮抗剂

    应用:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
  • 宿主种属: 人(Human)
  • 种属反应性: 人(Human)
  • 亚型: Human IgG2SA
  • 偶联: Unconjugated
有货

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
Ab175765-100μg
100μg 现货 Stock Image
Ab175765-1mg
1mg 现货 Stock Image
Ab175765-5mg
5mg 现货 Stock Image
Ab175765-10mg
10mg 期货 Stock Image

基本信息

产品名称 Fremanezumab (anti-CALCA), 降钙素基因相关肽拮抗剂的拮抗剂
别名 瑞玛奈珠单抗 | Fremanezumab(抗 CALCA)
英文别名 Calcitonin/calcitonin related polypeptide alpha antibody | Alpha type CGRP antibody | Beta type CGRP antibody | CALC1 antibody | CALC2 antibody | CALCA antibody | CALCB antibody | Calcitonin 1 antibody | Calcitonin 2 antibody | Calcitonin gene related pep
规格或纯度 无载体, 重组, ExactAb™, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
宿主种属 人(Human)
特异性 CALCA
种属反应性 人(Human)
偶联 Unconjugated
作用类型 拮抗剂
作用机制 降钙素基因相关肽拮抗剂的拮抗剂

产品属性

克隆类型 重组抗体
Format Whole IgG
亚型 Human IgG2SA
轻链亚型 kappa
SDS-PAGE 27.2 kDa (Light Chain) & 49.8 kDa (Heavy Chain), under reducing conditions; 160.5 kDa, under non-reducing conditions.
纯化方法 Protein A purified
纯度 >95% (SDS-PAGE&SEC)
物理外观 Liquid
储存缓冲液 Supplied as a 0.22μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0
防腐剂 No
浓度 见COA
储存温度 -80℃储存,避免反复冻融
运输条件 超低温冰袋运输
稳定性与储存 在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。
CAS编号和信息 1655501-53-3
分子类型 抗体

关联靶点(人)

CALCA Tclin 降钙素基因相关肽1(Calcitonin gene-related peptide 1) (0 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
CALCA Tbio 降钙素(Calcitonin) (0 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
CALCA Tclin Calcitonin gene-related peptide 1 (214 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID

作用机制

作用机制 Action Type target ID Target Name Target Type Target Organism Binding Site Name 参考文献

图片

Fremanezumab (anti-CALCA) (Ab175765) - ELISA
Immobilized hu-CALCA-KLH at 2 μg/mL can bind Fremanezumab (anti-CALCA) (Ab175765) with the EC₅₀ of 6.76 ng/mL.

Fremanezumab (anti-CALCA) (Ab175765) - SEC
The purity of Fremanezumab (anti-CALCA) (Ab175765) is more than 95% verified by HPLC.

质检证书(CoA,COO,BSE/TSE 和分析图谱)

C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:

通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!

找到6个结果

批号(Lot Number) 证书类型 货号
ZJ25F0724328 分析证书 Ab175765
ZJ25F0724327 分析证书 Ab175765
ZJ25F0724326 分析证书 Ab175765
ZJ24F0404235 分析证书 Ab175765
ZJ24F0404234 分析证书 Ab175765
ZJ24F0404233 分析证书 Ab175765

可替换产品

引用文献

1. Recober A, Russo AF.  (2007)  Olcegepant, a non-peptide CGRP1 antagonist for migraine treatment..  IDrugs,  10  (8): (566-74).  [PMID:17665333]
2. Migliore M, Habrant D, Sasso O, Albani C, Bertozzi SM, Armirotti A, Piomelli D, Scarpelli R.  (2016)  Potent multitarget FAAH-COX inhibitors: Design and structure-activity relationship studies..  Eur J Med Chem,  109  (216-37).  [PMID:26774927]
3. Xu R, Wang K, Rizzi JP, Huang H, Grina JA, Schlachter ST, Wang B, Wehn PM, Yang H, Dixon DD et al..  (2019)  3-[(1S,2S,3R)-2,3-Difluoro-1-hydroxy-7-methylsulfonylindan-4-yl]oxy-5-fluorobenzonitrile (PT2977), a Hypoxia-Inducible Factor 2α (HIF-2α) Inhibitor for the Treatment of Clear Cell Renal Cell Carcinoma..  J Med Chem,  62  (15): (6876-6893).  [PMID:31282155]
4. Miranda LP, Holder JR, Shi L, Bennett B, Aral J, Gegg CV, Wright M, Walker K, Doellgast G, Rogers R, Li H, Valladares V, Salyers K, Johnson E, Wild K..  (2008)  Identification of potent, selective, and metabolically stable peptide antagonists to the calcitonin gene-related peptide (CGRP) receptor..  J Med Chem,  51  (24): (7889-7897).  [PMID:19053766] [10.1021/jm8009298]
5. Civiello RL, Han X, Beno BR, Chaturvedula PV, Herbst JJ, Xu C, Conway CM, Macor JE, Dubowchik GM..  (2016)  Synthesis and SAR of calcitonin gene-related peptide (CGRP) antagonists containing substituted aryl-piperazines and piperidines..  Bioorg Med Chem Lett,  26  (4): (1229-1232).  [PMID:26832218] [10.1016/j.bmcl.2016.01.026]
6. Waszkielewicz AM, Gunia-Krzyżak A, Powroźnik B, Słoczyńska K, Pękala E, Walczak M, Bednarski M, Żesławska E, Nitek W, Marona H..  (2016)  Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents..  Bioorg Med Chem,  24  (8): (1793-1810).  [PMID:26988801] [10.1016/j.bmc.2016.03.006]
7. Kitamura, K K and 5 more authors..  (1992)  Isolation and characterization of peptides which act on rat platelets, from a pheochromocytoma..  Biochemical and biophysical research communications,  (29): [PMID:1318039]
8. Breeze, A L AL, Harvey, T S TS, Bazzo, R R and Campbell, I D ID..  (1991)  Solution structure of human calcitonin gene-related peptide by 1H NMR and distance geometry with restrained molecular dynamics..  Biochemistry,  (15): [PMID:1988044]
9. Hubbard, J A JA and 5 more authors..  (1991)  Solution structures of calcitonin-gene-related-peptide analogues of calcitonin-gene-related peptide and amylin..  The Biochemical journal,  (1): [PMID:2039456]
10. Edbrooke, M R MR and 6 more authors..  (1985)  Expression of the human calcitonin/CGRP gene in lung and thyroid carcinoma..  The EMBO journal,  [PMID:2408883]
11. Broad, P M PM, Symes, A J AJ, Thakker, R V RV and Craig, R K RK..  (1989)  Structure and methylation of the human calcitonin/alpha-CGRP gene..  Nucleic acids research,  (12): [PMID:2571128]
12. Craig, R K RK and 7 more authors..  (1986)  Expression and function of the human calcitonin/alpha-CGRP gene in health and disease..  Biochemical Society symposium,  [PMID:3034287]
13. Petermann, J B JB, Born, W W, Chang, J Y JY and Fischer, J A JA..  (1987)  Identification in the human central nervous system, pituitary, and thyroid of a novel calcitonin gene-related peptide, and partial amino acid sequence in the spinal cord..  The Journal of biological chemistry,  (15): [PMID:3492492]
14. Jonas, V V and 7 more authors..  (1985)  Alternative RNA processing events in human calcitonin/calcitonin gene-related peptide gene expression..  Proceedings of the National Academy of Sciences of the United States of America,  [PMID:3872459]
15. Nelkin, B D BD and 5 more authors..  (1984)  Structure and expression of a gene encoding human calcitonin and calcitonin gene related peptide..  Biochemical and biophysical research communications,  (17): [PMID:6148938]
16. Morris, H R HR and 5 more authors..  (1984)  Isolation and characterization of human calcitonin gene-related peptide..  Nature,  [PMID:6609312]
17. Steenbergh, P H PH and 5 more authors..  (1984)  Calcitonin gene related peptide coding sequence is conserved in the human genome and is expressed in medullary thyroid carcinoma..  The Journal of clinical endocrinology and metabolism,  [PMID:6610687]
18. Dodick, David W DW and 13 more authors..  (2014)  Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial..  The Lancet. Neurology,  [PMID:25297013]
19. Monteith, David D and 8 more authors..  (2017)  Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the CGRP Binding Monoclonal Antibody LY2951742 (Galcanezumab) in Healthy Volunteers..  Frontiers in pharmacology,  [PMID:29089894]

溶液计算器